Breaking AI & Tech News Analyzed

The Rise of Louis Mosley as Palantir's Public Face The hall was packed with rightwing radicals when Louis Mosley heralded a coming revolution. Just as Oliver Cromwell – that “crusader for Christ and liberty” – routed King Charles I’s royalists, “a similar revolution is brewing today”, said the UK and Europe boss of Palantir. Globalism’s “twilight” was upon us, he said in a speech dotted with admiring mentions of the podcaster Joe Rogan and “Elon’s Doge”. Palantir's Controversial Stance and Mosley's Role It was not a typical peroration for a big UK government contractor with more than £600m in deals with the NHS, the Ministry of Defence and police. But Palantir, the world’s most controversial tech company, is no typical contractor. In recent years it has gained firm footholds across Britain’s public sector while appalling critics with its leadership’s rightwing rhetoric and its work for the US and Israeli militaries and Donald Trump’s ICE immigration crackdown. Mosley's Background and Connection to Palantir Mosley is an important figure at Palantir. He is not trained as a technologist, but worked in Tory politics, including spells as an assistant to Rory Stewart and as a councillor in the Royal Borough of Kensington and Chelsea. He read history at Oxford where he met his wife, Nura Khan, a fashion editor, with whom he has four children. He is more likely to be seen reading biographies – Aneurin Bevan and Stalin have been recent subjects – than coding manuals. The Challenges Facing Mosley and Palantir Calls are growing for Keir Starmer’s government to cut its ties with the company that was co-founded by the Trump-backing tech billionaire Peter Thiel. It means Mosley has become a lightning rod for public fear of a US tech takeover of the British state. It has fallen to him to fight back. Almost daily his boyish features can be seen defending Palantir against its critics on X.com, on podcasts and on BBC News sofas. The Future of Palantir and Mosley's Role Mosley has embraced the foundational idea of Palantir, launched after 9/11 to help the US win the war on terror. It was named after the all-seeing crystal stones from The Lord of the Rings, which, as Mosley later explained, “are made by the goodies – by elves – but they fall into the hands of the baddies – the wizards – and they get used for evil purposes”. It is, said Mosley, a constant reminder that “you’re building a very, very powerful tool, and in the wrong hands, very powerful tools can be extremely dangerous. But in the right hands, they can be used to do extraordinarily good things.”

The Public Backlash Against Palantir Over 229,000 people have signed two separate petitions calling on the UK government to sever all ties with the US tech giant Palantir. The campaign targets the company's controversial role in the NHS, police forces, and military, citing its involvement with ICE immigration enforcement and the Israeli military. The Scale of UK Public Sector Contracts Palantir currently holds a significant footprint in the UK public sector, with contracts valued at approximately £600m. Key areas of involvement include a £330m patient data contract with the NHS, a £240m deal with the Ministry of Defence, and ongoing discussions with the Metropolitan Police to utilize AI for criminal intelligence analysis. The PR War: Policy vs. Memes The conflict has escalated into a highly publicized battle between activists and Palantir's leadership. A UK MP described the company's manifesto as "the ramblings of a supervillain," while Green Party leader Zack Polanski and campaigner Jolyon Maugham have launched a podcast investigation. In response, Palantir's UK CEO, Louis Mosley, has engaged in a social media war, posting memes and challenging critics to public debates. Future Outlook: Can the Government Pivot? The Liberal Democrats have joined the calls to cancel the NHS contract and halt new deals. With Wes Streeting, the Health Secretary, facing pressure, the government faces a critical decision. The risk of reputational damage to the NHS and public trust in government data handling is high, potentially forcing a strategic pivot away from controversial private contractors.

Health‑service workers have voiced strong unease after it emerged that engineers from the controversial US tech firm Palantir were issued NHS.net email accounts. Those accounts unlock a directory containing contact details for as many as 1.5 million NHS staff members, as well as access to SharePoint file‑sharing and Microsoft Teams groups used by the service. Palantir’s engineers are supporting the rollout of the Federated Data Platform (FDP), a £300 million contract awarded in 2023 to link patient records across disparate NHS systems. The government touts FDP as a cornerstone of its plan to "reinvent the NHS" by moving from analogue to digital, promising faster diagnoses, better appointment allocation and more personalised treatment. While the use of NHS email accounts by external suppliers is not unprecedented, Palantir’s reputation for AI‑driven surveillance and military‑grade technology has amplified staff, patient and human‑rights concerns. Rory Gibson, a resident doctor, warned that his personal contact details should not be accessible to a company that also works on drone‑strike systems. The Guardian has identified at least six Palantir engineers who have been given NHS.net credentials. In response, a Palantir spokesperson argued that such access is "normal practice for government suppliers" and cited official guidance that government systems are more secure than external alternatives. Palantir claims its software has already yielded measurable benefits: 110,000 additional operations, a 15.3% reduction in discharge delays and a 6.8% rise in cancer diagnoses within 28 days of referral. The company stresses that it merely provides software, with data usage remaining under NHS control and subject to strict contractual confidentiality. David Rowland, director of the Centre for Health and the Public Interest, acknowledged that granting NHS email addresses may not breach rules but highlighted the "deep ethical concerns" that Palantir’s profit‑driven model clashes with NHS values. He called for a comprehensive review of which private firms receive public‑sector funding. Some NHS staff reported being placed in virtual Teams meetings with Palantir personnel who joined using NHS credentials, without any disclosure of their employer – a practice that further eroded trust. Under the NHSmail access policy, "independent sector organisations" delivering health and social‑care services nationally may use NHSmail. An unrestricted NHS.net account can reveal staff roles, locations, workplace details and even grant access to commercial "Blue Light" discounts. Palantir’s technology is already deployed by UK police forces and the Ministry of Defence, prompting critics to warn that its "drag‑and‑drop" interoperability could facilitate state overreach, including a potential British analogue of the US Immigration and Customs Enforcement agency. The firm’s founders include US businessman and former Trump supporter Peter Thiel and CEO Alex Karp, both known for advocating aggressive surveillance tools. Its UK arm is led by Louis Mosley, grandson of historic British fascist leader Oswald Mosley. An NHS spokesperson reiterated that all suppliers, including Palantir, operate strictly under NHS instruction, with data access governed by robust contractual confidentiality obligations.

Palantir’s claim that opposition to its NHS contract is driven by ideology was rebuked by Chi Onwurah, the Labour MP who chairs Parliament’s science, innovation and technology select committee. Onwurah said it is appropriate for ministers to explore a break‑clause option in the deal, underscoring the seriousness of the concerns raised. Louis Mosley, Palantir’s UK executive vice‑chair, had urged the government not to succumb to “ideologically motivated campaigners” as officials weighed a way out of a £330 million contract to deliver the Federated Data Platform (FDP) for NHS England. Ministers have now asked for advice on triggering the contract’s break clause amid growing scrutiny of Palantir’s expanding role in the public sector. The FDP is an AI‑enabled platform designed to integrate disparate health information across the NHS. Palantir already holds contracts with the Ministry of Defence, several police forces and the UK’s financial watchdog, the FCA. Onwurah’s cross‑party committee is set to publish its report in the coming weeks, covering the digital reorganisation of government services and the role of AI after a series of hearings that included experts, NHS leaders and representatives from companies such as Palantir. She identified three core issues: the manner in which the contract was awarded, the handling of patient data and the resulting trust deficit within the NHS, and the involvement of Peter Mandelson through his firm Global Counsel. “These are not fringe ideological concerns,” Onwurah told the Guardian. “They relate to contract transparency, vendor lock‑in, value for money and data security – matters that should concern everyone pushing the NHS towards digital transformation.” She added that the NHS’s post‑COVID fatigue and austerity‑driven burnout make any additional trust‑related resentment a significant barrier to progress. Onwurah noted that Palantir secured the contract after providing services to the NHS at a nominal cost – a tactic often used by large tech firms to position themselves as the most attractive government supplier. “It is right for the government to explore all options, including breaking the contract, given ongoing concerns about FDP uptake while Palantir remains at the helm,” she said. Liberal Democrat MP Martin Wrigley, also on the committee, urged the government to commission a new consortium of UK‑based tech experts to build a home‑grown NHS platform. During a previous committee appearance, Mosley accused British doctors of placing “ideology over patient interest” after they challenged the data‑processing contract. Speaking to the Times, Mosley warned that removing Palantir could jeopardise patient care and stall solutions to the NHS’s biggest challenges, arguing that the campaign against the firm would do more harm than good.

Palantir’s senior UK representative has warned ministers against yielding to ideologically motivated campaigners as they explore the possibility of terminating a £330 million NHS contract for the company’s Federated Data Platform (FDP).The FDP, an AI‑enabled system intended to unify patient information across the health service, is part of a broader portfolio that includes contracts with the Ministry of Defence, several police forces and the UK’s financial regulator.Louis Mosley, executive vice‑chair of Palantir UK, told The Times that abandoning the deal would jeopardise patient care and hinder progress on the NHS’s most pressing challenges. He highlighted that the platform is projected to generate £150 million in benefits by the end of the decade, delivering a £5 return for every pound spent.According to the Financial Times, senior officials have begun informal discussions about activating a break clause that would allow the FDP’s operation to be transferred to an alternative provider once the system becomes fully operational next year.Palantir, a US‑based data‑analytics firm with ties to the Israeli and US militaries and former U.S. Immigration and Customs Enforcement contracts, has faced sustained opposition from the British Medical Association, which has long criticised the use of its technology in patient‑care settings.Health officials acknowledge the reputational risk, noting that the controversy now extends beyond traditional Labour‑left and Green Party critics. A Department of Health and Social Care spokesperson emphasised that the FDP is designed to improve care coordination, accelerate cancer diagnoses and increase treatment capacity, while maintaining strict data‑security safeguards.Health Secretary Wes Streeting, speaking on the Guardian Politics Weekly podcast, recognised public unease about Palantir’s political affiliations, referencing founder Peter Thiel’s right‑wing connections. He reassured listeners that Palantir does not have direct access to patient data, stating, "The platform is operated by us; Palantir never sees the data."Adoption of Palantir’s technology within the NHS has risen from 118 to 151 organisations since June, though it remains short of the government’s target of 240 organisations by year‑end. Labour backbencher Clive Lewis noted that the issue is becoming a visible concern for voters, reflecting broader anxieties about AI and foreign‑owned infrastructure in critical public services.